MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Spinocerebellar ataxias(SCA)"

  • MDS Virtual Congress 2021

    Spinocerebellar ataxia (SCA) type 2 and type 8: a tale of two repeat expansions in a single patient

    J. Frey, T. Tholanikunnel, L. Kugelmann, M. Burns, S. Subramony (Gainesville, USA)

    Objective: To describe the rare occurrence of coexisting SCA Types 2 and 8 in a pediatric patient. Background: SCAs are a group of autosomal dominant…
  • MDS Virtual Congress 2021

    Extracerebellar Signs and Symptoms in 117 Korean Patients with Early-Stage Spinocerebellar Ataxia

    M. Kim, JH. Ahn, JK. Mun, EH. Choi, JS. Kim, J. Youn, JW. Cho (Jinju, Republic of Korea)

    Objective: In this study, extracerebellar signs and symptoms in Korean patients with early-stage spinocerebellar ataxia were investigated. Background: Spinocerebellar ataxias (SCAs) are the most common…
  • MDS Virtual Congress 2021

    Hot cross bun sign in progressive ataxia with ELVOL4 mutation

    M. Moreno-Escobar, R. Tripathi (Morgantown, USA)

    Objective: To describe a case of progressive gait abnormalities and bulbar dysfunction which was associated with genetic mutation and neuroimaging findings representative of spinocerebellar ataxia…
  • MDS Virtual Congress 2021

    CEREBELLAR COGNITIVE AFFECTIVE SYNDROME IN SPINOCEREBELLAR ATAXIA TYPE 3

    KH. Yap, S. Azmin, SH. Mat Desa, HN. Achok, N. Mohamed Ibrahim (Cheras, Malaysia)

    Objective: This preliminary study aims to examine whether motor and cognitive features in spinocerebellar ataxia type 3 (SCA3) are manifestations of a shared and parallel,…
  • MDS Virtual Congress 2020

    Spinocerebellar Ataxia Type 3 Presenting with Motor Neuron Disease

    C. Jaques, J. Pedroso, A. Rocha, W. Pinto, A. Oliveira, O. Barsottini (São Paulo, Brazil)

    Objective: Spinocerebellar ataxia type 3 (SCA3) is associated with a wide spectrum of clinical manifestations, including peripheral neuropathy and amyotrophy, in addition to other motor…
  • MDS Virtual Congress 2020

    The genetic study of autosomal dominant spinocerebellar ataxia in Kazakhstan

    R. Kaiyrzhanov, N. Zharkinbekova, A. Aitkulova, J. Jarmukhanov, V. Akhmetzhanov, A. Taskynbayeva, C. Shashkin (Shymkent, Kazakhstan)

    Objective: To perform the genetic study of autosomal dominant spinocerebellar ataxia (ADSCA) cases from Kazakhstan. Background: Spinocerebellar ataxias (SCAs) is a large group of hereditary…
  • MDS Virtual Congress 2020

    Novel Mutation in the Protein Kinase C Gamma Gene Causing Spinocerebellar Ataxia-14 in a Large Family

    J. Lahrmann, M. Dagostine, D. Machado (Cheshire, CT, USA)

    Objective: To report a novel mutation not been previously reported in large, multi-ethnic general populations, in the protein kinase C gamma (PRKCG) gene causing spinocerebellar ataxia…
  • MDS Virtual Congress 2020

    Prevalence and Clinical Profile of Common Spinocerebellar Ataxia in Malaysia

    L.U Lau, M.D Hajar, Y.S Yakob, M.D Ibrahim (Kuala Lumpur, Malaysia)

    Objective: To describe prevalence and demographics of Spinocerebellar Ataxia (SCA) 1,2,3,6 and 7, and the phenotypic characteristics of SCA 3 patients in Malaysia. Background: Spinocerebellar…
  • MDS Virtual Congress 2020

    An unusual phenotype of spinocerebellar ataxia type 12

    K. Neeraja, V. Holla, S. Prasad, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)

    Objective: To describe a case of spinocerebellar ataxia type 12 (SCA-12) with an unusual phenotype. Background: SCA-12 is a rare autosomal dominant cerebellar ataxia which…
  • MDS Virtual Congress 2020

    Amantadine Therapy for Ataxia Management in Patients with Spinocerebellar Ataxia Type 7

    L. Pesantez Pacheco, N. Thakur (Houston, TX, USA)

    Objective: To report the therapeutic effects of amantadine in a patient with Spinocerebellar ataxia type 7 (SCA7) Background: Spinocerebellar ataxia type 7 is a rare…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 14
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley